All Inventions from Dr. Peter Kwong

  • Newcastle Disease Virus-Like Particle Displaying Prefusion Stabilized SARS-CoV-2 Spike and Its Use
    •
       Ref: E-068-2021-0 | Updated: Apr 23, 2021 | NIAID
  • Prefusion-Stabilized Fusion (F) Glycoprotein Vaccine Immunogens For Human Metapneumovirus
    •
       Ref: E-131-2019-0 | Updated: Jan 26, 2021 | NIAID
  • Structure-Based Design of SARS-CoV-2 Spike Immunogens Stabilized in the RBD-All Down Conformation
    •
       Ref: E-187-2020-0 | Updated: Oct 5, 2020 | NIAID
  • Improvement of Broadly HIV-Neutralizing Antibodies; Anti-HIV-1 Antibody VRC01.23 for Prevention or Treatment of HIV...
    •
       Ref: E-034-2018-0 | Updated: Mar 9, 2020 | NIAID
  • Recombinant HIV-1 Envelope Proteins and Their Use
    •
       Ref: E-240-2017-0 | Updated: Sep 5, 2019 | NIAID
  • Optimized Variants of the Broadly Neutralizing HIV-1 gp41 Antibody, 10E8
    •
       Ref: E-133-2015-0 | Updated: Nov 19, 2018 | NIAID
  • Fusion Glycoprotein Vaccine for Human Metapneumovirus
    •
       Ref: E-260-2014-0 | Updated: Oct 29, 2018 | NIAID
  • Recombinant HIV-1 Envelope Protein for Vaccine Use
    •
       Ref: E-178-2014-0 | Updated: Oct 18, 2018 | NIAID
  • HIV-1 Env Fusion Peptide Immunogens and Their Use
    •
       Ref: E-279-2016-0 | Updated: Oct 17, 2018 | NIAID
  • Self-assembling Insect Ferritin Nanoparticles for Display of Co-assembled Trimeric Antigens
    •
       Ref: E-270-2015-0 | Updated: Oct 17, 2018 | NIAID
  • Substitutions-Modified Prefusion RSV F Proteins and Their Use
    •
       Ref: E-064-2016-0 | Updated: Oct 17, 2018 | NIAID
  • Prefusion HPIV F Immunogens and Their Use.
    •    Ref: E-215-2016-0 | Updated: Aug 31, 2018 | NIAID
  • Recombinant Paramyxoviruses Expressing Optimized Heterologous Antigens
    •
       Ref: E-241-2014-0 | Updated: Jul 3, 2018 | NIAID
  • Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
    •
       Ref: E-300-2009-0 | Updated: Jun 22, 2018 | NIAID
  • Neutralizing Antibodies to Influenza HA and Their Use and Identification
    •
       Ref: E-061-2016-0 | Updated: Jun 22, 2018 | NIAID
  • Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine
    •
       Ref: E-081-2013-0 | Updated: Jun 22, 2018 | NIAID
  • Stabilized Influenza Hemagglutinin Stem Region Trimers and Uses Thereof
    •
       Ref: E-066-2014-0 | Updated: Jun 22, 2018 | NIAID
  • Resurfaced Stabilized Core 3 (RSC3) Protein, Derived Proteins, and DNA Encoding These Proteins: RSC3, RSC3...
    •
       Ref: E-236-2016-0 | Updated: Jun 7, 2018 | NIAID
  • N6, A Novel, Broad, Highly Potent HIV-specific Antibody
    •    Ref: E-131-2015-0 | Updated: Mar 15, 2017 | NIAID
  • Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most...
    •
       Ref: E-253-2011-0 | Updated: Jun 18, 2014 | NIAID
  • Novel System for HIV-1 Vaccine Development
    •
       Ref: E-218-2004-0 | Updated: Mar 1, 2007 | NIAID

    Displaying 1 - 21 of 21

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057